(Q33831409)

English

Disease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

Disease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature (English)

1 reference

Europe PubMed Central

29 July 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Sokka T

1

1 reference

Europe PubMed Central

29 July 2017

Möttönen T

2

1 reference

Europe PubMed Central

29 July 2017

Hannonen P

3

1 reference

Europe PubMed Central

29 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2000

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

39

1 reference

Europe PubMed Central

29 July 2017

1

1 reference

Europe PubMed Central

29 July 2017

34-42

1 reference

Europe PubMed Central

29 July 2017

Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Long-term outcome of treating rheumatoid arthritis: results after 20 years

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Outcome of second line therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Predictors of work disability in rheumatoid arthritis patients. A five-year followup

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

In-patient treatment for active rheumatoid arthritis: clinical course and predictors of improvement

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Health care utilization and outcomes among persons with rheumatoid arthritis in fee-for-service and prepaid group practice settings

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. An open-label extension study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.1.34

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/39.1.34

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33831409&oldid=1969966419"